Society for Integrative Oncology
A new, worldwide organization of oncology professionals studying and integrating effective complementary therapies in cancer care
1st International Conference
Marriott Marquis Times Square November 17 – 19, 2004 The Society for Integrative Oncology (SIO) invites you to submit an abstract electronically for a platform or poster presentation at its 1st International Conference, November 17-19, 2004. Abstracts may be submitted on the following topics: • Complementary Therapies for Common Physical Symptoms • Complementary Therapies for Common Emotional Symptoms • Botanicals in the Treatment of Cancer • Botanicals in the Treatment of Cancer-Related Symptoms • Phytoestrogens and Antioxidants • Complementary Therapies for Breast, Prostate, GI, and Lung Cancer Abstracts may be submitted through the SIO website, www.integrativeonc.com (click “Abstract submission”) March 1, 2004 through June 1, 2004. Submitters receive decision notification by July 15, 2004.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of American Cancer Society and Society for Integrative Oncology. The American Cancer Society is accredited by the ACCME to provide continuing medical education for physicians.
Registration and Conference Information available at www.integrativeonc.com
Save the Date & Call for Abstracts
IN COLLABORATION WITH
Memorial Sloan-Kettering Cancer Center; Dana Farber Cancer Institute; University of Texas M. D. Anderson Cancer Center; American Cancer Society; International Union against Cancer (UICC); American Society for Clinical Oncology (ASCO); American Society for Therapeutic Radiology and Oncology (ASTRO); Susan G. Komen Breast Cancer Foundation; National Alliance of Breast Cancer Organizations (NABCO); National Institute for Cancer Research, Genoa, Italy; European School of Oncology (ES0), Milan; American-Italian Cancer Foundation; National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM), National Comprehensive Cancer Network (NCCN)
State of the Art and Science of Integrative Oncology Complementary Therapies for Common Physical Symptoms Complementary Therapies for Common Emotional Symptoms Implementing Complementary Therapies Botanicals in the Treatment of Cancer Botanicals in the Treatment of Cancer-Related Symptoms Phytoestrogens and Antioxidants Complementary Modalities for Breast, Prostate, GI and Lung Cancer Integrative Modalities and their Utility in Cancer Care
CONFERENCE TOPICS
Society for Integrative Oncology 1st International Conference 19 Mantua Road Mt. Royal, New Jersey 08061 856-423-7222 SIOMEETINGS@Talley.com www.integrativeonc.com
Andrew von Eschenbach, MD, Director, National Cancer Institute, Bethesda, Maryland
KEYNOTE SPEAKER
CONFERENCE FACULTY
Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center; New York (Conference Chair) Lorenzo Cohen, PhD, Director, Integrative Medicine Program and Chief, Section of Integrative Medicine, Departments of Behavioral Science and Palliative Care & Rehabilitation Medicine, University of Texas M. D. Anderson Cancer Center; Houston C. Norman Coleman, MD, Director, Radiation Oncology Sciences Program, Chief, Radiation Oncology Branch, Deputy Director, Center for Cancer Research, Associate Director, Radiation Research Program and Special Advisor to the Director, National Cancer Institute; Bethesda, Maryland Jacqueline Filshie, MD, Consultant Anaesthetist, Royal Marsden Hospital Honorary Senior Lecturer, Institute of Cancer Research; Secretary, British Medical Acupuncture Society, London Patricia Ganz, MD, Professor of Health Services and Medicine, UCLA School of Public Health; Director, Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, UCLA; Los Angeles Waun Ki Hong, MD, American Cancer Society Professor; Division Head, Cancer Medicine; Professor and Chair, Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center; Houston Michelle Kohn, MD, MBBS, BSc, MRCP (UK), Complementary Therapies Medical Advisor to Macmillan Cancer Relief Fund; Advisor, Department of Health, United Kingdom; London Amy S. Langer, Executive Director, National Alliance of Breast Cancer Organizations (NABCO); New York Fred P. Li, MD, Dana-Farber Cancer Institute, Boston Charles L. Loprinzi, MD, Professor of Oncology, Mayo Clinic; Rochester, Minnesota Ray Lowenthal, MD, FRCP FRACP FAChPM, Director of Medical Oncology, Royal Hobart Hospital; Clinical Professor, University of Tasmania; President, Cancer Council of Australia
Lucio Luzzatto, MD, Scientific Director, Istituto Nazionale per la Ricerca sul Cancro; Genoa Larry Norton, MD, Deputy Physician-in-Chief for Breast Cancer Programs, Memorial Sloan-Kettering Cancer Center; Chair, Breast Committee, CaLGB; President, NABCO; Past President, ASCO; Member, National Cancer Advisory Board; New York Raphael E. Pollock, MD, PhD, Division Head, Surgery; Professor and Chair, Surgical Oncology; Professor, Molecular & Cellular Oncology, MD Anderson Cancer Center; Houston Russell K. Portenoy, MD, Chair, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center; Professor of Neurology, Albert Einstein College of Medicine; New York Eliezer Robinson, MD, Immediate Past President, International Union against Cancer (UICC); Chair, National Council for Oncology and Israeli Cancer Association; Haifa David S. Rosenthal, MD, Professor of Medicine, Harvard Medical School; Medical Director, Leonard P. Zakim Center for Integrated Therapies; DanaFarber Cancer Institute; Past President, American Cancer Society, Boston Hope Rugo, MD, Clinical Professor of Medicine, Co-Director, Breast Oncology Clinical Trials Program, UCSF-Comprehensive Cancer Center, San Francisco Stephen M. Sagar, MB.BS, MRCP, FRCR, FRCP(C), Associate Professor, Medicine, McMaster University, Radiation Oncologist, Juravinski Regional Cancer Centre, Hamilton Health Sciences Centre, Ontario Joel E. Tepper, MD, Professor and Chair, Department of Radiation Oncology, University of North Carolina at Chapel Hill; President, American Society for Therapeutic Radiology and Oncology; Chapel Hill Debasish Tripathy, MD, Professor of Medicine and Director, Komen/ UT Southwestern Breast Cancer Research Program, University of Texas Southwestern Medical Center, Dallas